ストックスクリーナーアプリを入手
3.97
0.25%
-0.010
アフターアワーズ：
3.87
-0.10
-2.52%
前日終値:
$3.98
開ける：
$3.88
24時間の取引高:
24,558
Relative Volume:
0.02
時価総額：
$21.35M
収益：
$15.66M
当期純損益:
$5.83M
株価収益率:
-0.1662
EPS:
-23.8939
ネットキャッシュフロー:
$466.20K
1週間 パフォーマンス:
+2.32%
1か月 パフォーマンス:
-7.03%
6か月 パフォーマンス:
-44.55%
1年 パフォーマンス:
+11.20%
1日の値動き範囲:
$3.82
$3.9799
1週間の範囲:
$3.80
$4.00
52週間の値動き範囲:
$3.00
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
NEUP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
3.97 | 21.40M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 繰り返されました | Maxim Group | Buy |
| 2022-01-10 | 開始されました | Berenberg | Buy |
| 2022-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 開始されました | Evercore ISI | Outperform |
| 2022-01-10 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Neuphoria Therapeutics Inc (NEUP) 最新ニュース
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
2026 world cup team news comparison: How buybacks impact Neuphoria Therapeutics Inc. stock value2026 world cup usa national team round of 32 goalkeepers low block defense match prediction expert opinion - ulpravda.ru
Neuphoria Therapeutics to receive $15M milestone payment from Merck - MSN
Aug Intraday: Will Neuphoria Therapeutics Inc stock outperform Dow Jones indexShare Buyback & Low Risk Growth Stock Ideas - moha.gov.vn
Weekly Recap: Why Neuphoria Therapeutics Inc. stock could outperform in 2025Insider Buying & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
What risks investors should watch in Neuphoria Therapeutics Inc. stockMarket Activity Recap & Fast Entry High Yield Stock Tips - bolumsonucanavari.com
Published on: 2025-12-20 20:44:19 - Улправда
Published on: 2025-12-20 15:41:19 - Улправда
Why Neuphoria Therapeutics Inc. stock remains on watchlistsIPO Watch & Weekly Return Optimization Alerts - Улправда
Will Neuphoria Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Chart Watch & Daily Entry Point Alerts - DonanımHaber
How Neuphoria Therapeutics Inc. stock reacts to global recession fears2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
Is Neuphoria Therapeutics Inc. stock positioned for digital transformationWeekly Risk Summary & Weekly Stock Breakout Alerts - DonanımHaber
Does Neuphoria Therapeutics Inc. stock trade at a discount to peersWeekly Trend Summary & Smart Investment Allocation Insights - DonanımHaber
How Neuphoria Therapeutics Inc. stock benefits from global expansionJuly 2025 Drop Watch & Accurate Buy Signal Notifications - DonanımHaber
Neuphoria Therapeutics (NEUP) details 2025 annual meeting and vote outcomes - Stock Titan
Neuphoria Therapeutics (NASDAQ:NEUP) Cut to Strong Sell at Zacks Research - Defense World
Abeona Therapeutics (NASDAQ:ABEO) and Neuphoria Therapeutics (NASDAQ:NEUP) Critical Comparison - Defense World
ISS recommends shareholders vote for Neuphoria’s board nominees By Investing.com - Investing.com Australia
Leading Advisory Firms Recommend Voting FOR Lynx1's Independent Nominees - Yahoo Finance
Institutional Shareholder Services Recommends Shareholders of Neuphoria to Vote for its Director Nominees - marketscreener.com
ISS recommends shareholders vote for Neuphoria’s board nominees - Investing.com
Neuphoria Therapeutics (NEUP) Gains ISS Support for Director Nom - GuruFocus
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees - The Manila Times
HC Wainwright Has Lowered Expectations for Neuphoria Therapeutics (NASDAQ:NEUP) Stock Price - Defense World
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail
Neuphoria Therapeutics (NEUP) Stock Analysis Report | Financials & Insights - Benzinga
HC Wainwright & Co. Maintains Neuphoria Therapeutics (NEUP) Buy Recommendation - Nasdaq
NEUP: Analyst Lowers Price Target by 66% but Maintains 'Buy' Rat - GuruFocus
Neuphoria continues strategic review amid reduced takeover offer By Investing.com - Investing.com Nigeria
Will Neuphoria Therapeutics Inc. stock deliver strong dividend growthIPO Watch & Weekly Watchlist for Hot Stocks - Newser
Neuphoria Therapeutics (NEUP) Considers Strategic Alternatives A - GuruFocus
Neuphoria continues strategic review amid reduced takeover offer - Investing.com
Neuphoria responds to Lynx1's revised indication of interest at a reduced price and premium - marketscreener.com
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium - The Manila Times
Neuphoria Therapeutics Inc (NEUP) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):